COMP <GO>
INSM vs UNH // FORWARD P/E MULTIPLE
Insmed Incorporated (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: INSM 4
— UNH 10
▲ FORWARD P/E MULTIPLE LEADER: UNH
LAST: $112.58 (+0.89%) • MKT CAP: $24.37B
forward-pe
21.0x
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
forward-pe
17.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INSM VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INSM | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.70% | 88.57% | -8.87 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 11.47% | -46.47 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.97% | 6.48% | -10.45 | UNH | /fcf-yield <GO> |
| Operating Margin | -60.00% | 4.82% | -64.82 | UNH | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 3.14% | -63.14 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 66.70% | 6.46% | +60.24 | INSM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.25 | 3.12 | +2.13 | INSM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.74% | +0.26 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.7 | 56.0 | +6.68 | INSM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.03 | 0.33 | +0.70 | INSM | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 21.0x | 17.1x | +3.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $24.37B | $364.66B | -$340.29B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INSM REV | UNH REV | INSM GROSS % | UNH GROSS % | INSM FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $606.4M | $447.57B | 79.7% | 88.7% | -$967.6M | $16.07B |
| FY 2024 | $363.7M | $400.28B | 76.4% | 88.3% | -$705.8M | $20.70B |
| FY 2023 | $305.2M | $371.62B | 44.0% | 89.6% | -$550.0M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INSM // BETA 1.03
UNH // BETA 0.33